Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Novus Biologicals™ Rat CD30/TNFRSF8 ELISA Kit (Colorimetric)
SDP

Catalog No. NB398266 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
1 Kit
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB398266 1 Kit
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB398266 Supplier Novus Biologicals™ Supplier No. NBP282140
Add to Cart
Add to Cart

Kit (Colorimetric)

Specifications

Assay Range 1.56 to 100 ng/mL
Assay Sensitivity 0.94 ng/mL
Immunoassay Kit Format Colorimetric Detection Kit
Product Type ELISA Kit (Colorimetric)
Sample Type Serum, Plasma, Cell Supernatant
Specificity This kit recognizes Rat CD30/TNFRSF8 in samples. No Significant cross-reactivity or interference between Rat CD30/TNFRSF8 and analogues was observed.
Target Species Rat
For Use With (Application) ELISA
Gene ID (Entrez) 943
Gene Symbol TNFRSF8
Quantity 1 Kit
Research Discipline Apoptosis, B Cell Development and Differentiation Markers, Cell Cycle and Replication, Immunology, Stem Cell Markers
Storage Requirements Storage of components varies. See protocol for specific instructions.
Synonym CD30, CD30 antigen, CD30KI-1, CD30L receptor, cytokine receptor CD30, D1S166EKi-1, Ki-1 antigen, Lymphocyte activation antigen CD30, tumor necrosis factor receptor superfamily member 8, tumor necrosis factor receptor superfamily, member 8
Target Rat
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.